Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COIN trial of low-dose colchicine for small abdominal aortic aneurysm growth
ChiCTR2100046776Phase 4Recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Sep 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in abdominal aortic aneurysm (AAA) comparing Colchicine group with Placebo group (2 arms). Primary endpoints: Change in maximum abdominal aortic aneurysm diameter by angiography and Change in maximum abdominal aortic aneurysm diameter by ultrasound. Started Sep 2021; status: recruiting.
02
Drugs
colchicine
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on ChiCTR2100046776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046776.